Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
MELVILLE, N.Y., Dec 29, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065,...
GAITHERSBURG, Md., Dec 16, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG)(OTCQX: RHHBY), announced...
MOTTEP Honors Astellas for Commitment to Transplant Community Deerfield, IL (December 7, 2009) – Astellas Pharma US, Inc. was inducted into the National Minority Organ Tissue Transplant...
Read more about Astellas Inducted into National Minority Transplant Hall of Fame
MELVILLE, N.Y., Nov 16, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva(R)...
SOUTH SAN FRANCISCO, CA and DEERFIELD, IL – November 5, 2009 – Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV™ (telavancin) in...
Vancouver, Canada and Deerfield, Illinois, USA, October 28, 2009 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and its co-development partner Astellas Pharma US, Inc. (“Astellas”)...
Read more about Cardiome and Astellas Announce Initiation of Patient Enrollment in Act 5 Trial
Challenge to state of Illinois: 5,000 new organ donor registrations by the end of the year Deerfield, IL (October 26, 2009) – On November 1, 1999 Chicago Bears fans and the organ donation...
Data Published in Headache Highlights Bioequivalence, Safety and Ease of Use SAN DIEGO, CA and Deerfield, IL - (October 22, 2009): Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical...
Study finds aminophylline needs comparable to current standard Minneapolis – October 2, 2009 – A new analysis reaffirms that Lexiscan® (regadenoson) Injection, the first selective A2A...
DEERFIELD, IL, September 22, 2009 – Astellas Pharma US, Inc. has announced the winners of the first annual Astellas Transplant Scholars Awards, $5,000 educational scholarships awarded to six...
Follow U.S. news
